A carregar...
Are we fully exploiting type I Interferons in today's fight against COVID-19 pandemic?
Coronavirus disease 2019 (COVID-19) first emerged in late 2019 in China. At the time of writing, its causative agent SARS-CoV-2 has spread worldwide infecting over 9 million individuals and causing more than 460,000 deaths. In the absence of vaccines, we are facing the dramatic challenge of controll...
Na minha lista:
| Publicado no: | Cytokine Growth Factor Rev |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Elsevier Ltd.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7334951/ https://ncbi.nlm.nih.gov/pubmed/32665127 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cytogfr.2020.07.010 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|